Champions Oncology Inc
NASDAQ:CSBR
Champions Oncology Inc
NASDAQ:CSBR
Price:
4.9 USD
-4.48%
Market Closed
Updated:
May 7, 2024
Champions Oncology Inc
Operating Income
|
Champions Oncology Inc
Operating Income Peer Comparison
Comparables:
TMO
DHR
WST
A
IQV
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Champions Oncology Inc
NASDAQ:CSBR
|
Operating Income
-$9.6m
|
CAGR 3-Years
-120%
|
CAGR 5-Years
-115%
|
CAGR 10-Years
-5%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Operating Income
$7.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
|
|
Danaher Corp
NYSE:DHR
|
Operating Income
$9.5B
|
CAGR 3-Years
20%
|
CAGR 5-Years
26%
|
CAGR 10-Years
12%
|
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Operating Income
$661.6m
|
CAGR 3-Years
9%
|
CAGR 5-Years
20%
|
CAGR 10-Years
15%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Operating Income
$1.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
6%
|
CAGR 10-Years
16%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Operating Income
$2.1B
|
CAGR 3-Years
38%
|
CAGR 5-Years
21%
|
CAGR 10-Years
16%
|
See Also
What is Champions Oncology Inc's Operating Income?
Operating Income
-9.6m
USD
-9.6m
USD
Based on the financial report for Jan 31, 2024, Champions Oncology Inc's Operating Income amounts to -9.6m USD.
What is Champions Oncology Inc's Operating Income growth rate?
Operating Income CAGR 10Y
-5%
-5%
Over the last year, the Operating Income growth was -216%. The average annual Operating Income growth rates for Champions Oncology Inc have been -120% over the past three years , -115% over the past five years , and -5% over the past ten years .
You don't have any saved screeners yet
